- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 223/24 - Dibenz [b, f] azepinesHydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
Patent holdings for IPC class C07D 223/24
Total number of patents in this class: 14
10-year publication summary
|
2
|
2
|
0
|
2
|
0
|
1
|
1
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5815 |
1 |
| Idemitsu Kosan Co., Ltd. | 4224 |
1 |
| CoLucid Pharmaceuticals, Inc. | 14 |
1 |
| Dr. Reddy's Laboratories, Inc. | 180 |
1 |
| Dr. Reddy's Laboratories Limited | 555 |
1 |
| Glenmark Generics Ltd. | 36 |
1 |
| Hiroshima University | 563 |
1 |
| Mallinckrodt LLC | 132 |
1 |
| Ranbaxy Laboratories Limited | 307 |
1 |
| Tokyo University of Pharmacy & Life Sciences | 37 |
1 |
| The University of Tokyo | 4189 |
1 |
| Watson Laboratories, Inc. | 16 |
1 |
| Fundacio Institut Catala D'investigacio Quimica | 4 |
1 |
| Rappta Therapeutics Oy | 9 |
1 |
| Other owners | 0 |